Jiřı́ Suttnar

1.6k total citations
103 papers, 1.2k citations indexed

About

Jiřı́ Suttnar is a scholar working on Hematology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Jiřı́ Suttnar has authored 103 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 38 papers in Pulmonary and Respiratory Medicine and 26 papers in Molecular Biology. Recurrent topics in Jiřı́ Suttnar's work include Blood properties and coagulation (37 papers), Platelet Disorders and Treatments (19 papers) and Erythrocyte Function and Pathophysiology (13 papers). Jiřı́ Suttnar is often cited by papers focused on Blood properties and coagulation (37 papers), Platelet Disorders and Treatments (19 papers) and Erythrocyte Function and Pathophysiology (13 papers). Jiřı́ Suttnar collaborates with scholars based in Czechia, Poland and United States. Jiřı́ Suttnar's co-authors include Jan E. Dyr, Jaroslav Čermák, Roman Kotlín, Zuzana Reicheltová, Pavel Májek, Tomáš Riedel, Martin Malý, Jiřı́ Homola, Peter Salaj and Kristýna Pimková and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Jiřı́ Suttnar

100 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiřı́ Suttnar Czechia 20 415 339 301 129 121 103 1.2k
Jan E. Dyr Czechia 22 515 1.2× 392 1.2× 347 1.2× 257 2.0× 113 0.9× 104 1.6k
T. Stief Germany 18 223 0.5× 330 1.0× 253 0.8× 65 0.5× 150 1.2× 98 1.2k
Taher Nassar Israel 27 508 1.2× 228 0.7× 201 0.7× 109 0.8× 126 1.0× 51 1.9k
Marilena Crescente United Kingdom 19 249 0.6× 204 0.6× 135 0.4× 214 1.7× 64 0.5× 40 1.2k
Thomas Lehmann Switzerland 22 866 2.1× 623 1.8× 253 0.8× 72 0.6× 128 1.1× 60 2.2k
Laura Chiarantini Italy 24 686 1.7× 98 0.3× 182 0.6× 151 1.2× 465 3.8× 77 1.7k
Reheman Adili United States 28 509 1.2× 897 2.6× 253 0.8× 133 1.0× 133 1.1× 61 2.4k
Shenghui Zhang China 24 780 1.9× 443 1.3× 110 0.4× 99 0.8× 109 0.9× 99 2.3k
Rui Yang China 31 1.3k 3.2× 254 0.7× 152 0.5× 177 1.4× 114 0.9× 115 2.8k

Countries citing papers authored by Jiřı́ Suttnar

Since Specialization
Citations

This map shows the geographic impact of Jiřı́ Suttnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiřı́ Suttnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiřı́ Suttnar more than expected).

Fields of papers citing papers by Jiřı́ Suttnar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiřı́ Suttnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiřı́ Suttnar. The network helps show where Jiřı́ Suttnar may publish in the future.

Co-authorship network of co-authors of Jiřı́ Suttnar

This figure shows the co-authorship network connecting the top 25 collaborators of Jiřı́ Suttnar. A scholar is included among the top collaborators of Jiřı́ Suttnar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiřı́ Suttnar. Jiřı́ Suttnar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burda, Pavel, et al.. (2024). Imatinib therapy of chronic myeloid leukemia significantly reduces carnitine cell intake, resulting in adverse events. Molecular Metabolism. 88. 102016–102016. 1 indexed citations
2.
Mandys, Václav, et al.. (2023). Oxidative Stress as a Reliable Biomarker of Carotid Plaque Instability: A Pilot Study. Antioxidants. 12(2). 506–506. 3 indexed citations
3.
Suttnar, Jiřı́, et al.. (2022). Long-Term Effects on the Lipidome of Acute Coronary Syndrome Patients. Metabolites. 12(2). 124–124. 8 indexed citations
4.
Sovová, Žofie, et al.. (2022). Structural and Functional Characterization of Four Novel Fibrinogen Mutations in FGB Causing Congenital Fibrinogen Disorder. International Journal of Molecular Sciences. 23(2). 721–721. 5 indexed citations
5.
Beličková, Monika, Michaela Dostálová Merkerová, Zdeněk Krejčík, et al.. (2021). Low Plasma Citrate Levels and Specific Transcriptional Signatures Associated with Quiescence of CD34+ Progenitors Predict Azacitidine Therapy Failure in MDS/AML Patients. Cancers. 13(9). 2161–2161. 2 indexed citations
6.
Malý, Martin, et al.. (2021). Lipidomic Analysis to Assess Oxidative Stress in Acute Coronary Syndrome and Acute Stroke Patients. Metabolites. 11(7). 412–412. 18 indexed citations
7.
Sovová, Žofie, et al.. (2021). Extension of the Human Fibrinogen Database with Detailed Clinical Information—The αC-Connector Segment. International Journal of Molecular Sciences. 23(1). 132–132. 1 indexed citations
8.
Sovová, Žofie, Jiřı́ Suttnar, & Jan E. Dyr. (2021). Molecular Dynamic Simulations Suggest That Metabolite-Induced Post-Translational Modifications Alter the Behavior of the Fibrinogen Coiled-Coil Domain. Metabolites. 11(5). 307–307. 9 indexed citations
9.
Sovová, Žofie, Pavel Májek, Jiřı́ Suttnar, et al.. (2020). Impact of posttranslational modifications on atomistic structure of fibrinogen. PLoS ONE. 15(1). e0227543–e0227543. 18 indexed citations
10.
Harant, Karel, Marie Heczková, Helena Daňková, et al.. (2019). The effect of ω-3 polyunsaturated fatty acids on the liver lipidome, proteome and bile acid profile: parenteral versus enteral administration. Scientific Reports. 9(1). 19097–19097. 14 indexed citations
11.
Pimková, Kristýna, Pavel Májek, Roman Kotlín, et al.. (2017). Enhanced plasma protein carbonylation in patients with myelodysplastic syndromes. Free Radical Biology and Medicine. 108. 1–7. 14 indexed citations
12.
Reicheltová, Zuzana, Tomáš Riedel, Pavel Májek, et al.. (2014). Abnormal Fibrinogen Zlín (γThr21Ile) with Missense Mutation Causing Hypofibrinogenemia. Acta Haematologica. 132(2). 140–143. 1 indexed citations
13.
Májek, Pavel, et al.. (2011). Plasma proteome changes in cardiovascular disease patients: novel isoforms of apolipoprotein A1. Journal of Translational Medicine. 9(1). 84–84. 27 indexed citations
14.
Pimková, Kristýna, Markéta Bocková, Kateřina Hegnerová, et al.. (2011). Surface plasmon resonance biosensor for the detection of VEGFR-1—a protein marker of myelodysplastic syndromes. Analytical and Bioanalytical Chemistry. 402(1). 381–387. 55 indexed citations
15.
Kotlín, Roman, et al.. (2010). Dysfibrinogenemia in childhood: two cases of congenital dysfibrinogens. Blood Coagulation & Fibrinolysis. 21(7). 640–648. 6 indexed citations
16.
Reicheltová, Zuzana, Martin Malý, Jiřı́ Suttnar, et al.. (2009). Two cases of congenital dysfibrinogenemia associated with thrombosis – Fibrinogen Praha III and Fibrinogen Plzeň. Thrombosis and Haemostasis. 102(9). 479–486. 15 indexed citations
17.
Kotlín, Roman, Tomáš Riedel, Peter Salaj, et al.. (2008). Acquired Dysfibrinogenemia Secondary to Multiple Myeloma. Acta Haematologica. 120(2). 75–81. 28 indexed citations
18.
Dyr, Jan E. & Jiřı́ Suttnar. (1997). Separation used for purification of recombinant proteins. Journal of Chromatography B Biomedical Sciences and Applications. 699(1-2). 383–401. 32 indexed citations
19.
Liška, Vladimír, Jan E. Dyr, Jiřı́ Suttnar, Ivan Hirsch, & Vladimı́r Vonka. (1994). Production and simple purification of a protein encoded by part of the gag gene of HIV-1 in the Escherichia coli HB101F+ expression system inducible by lactose and isopropyl-β-d-thiogalactopyranoside. Journal of Chromatography B Biomedical Sciences and Applications. 656(1). 127–133. 4 indexed citations
20.
Holada, Karel, Jan E. Dyr, Jiřı́ Suttnar, & Jan Šimák. (1991). Comparison of rat and human major platelet glycoproteins. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 99(2). 399–403. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan E. Dyr Breakdown of academic impact, for papers by T. Stief Breakdown of academic impact, for papers by Taher Nassar Breakdown of academic impact, for papers by Marilena Crescente Breakdown of academic impact, for papers by Thomas Lehmann Breakdown of academic impact, for papers by Laura Chiarantini Breakdown of academic impact, for papers by Reheman Adili Breakdown of academic impact, for papers by Shenghui Zhang Breakdown of academic impact, for papers by Rui Yang
Rankless by CCL
2026